Abstract
Introduction
During the past three decades policy makers from a number of developing countries have undertaken outward-oriented economic reforms with a view to stimulating the acquisition of global capabilities and promoting greater domestic economic activity. The liberalization of trade and foreign direct investment regimens have been two important features of such reforms, which have resulted in firms from developing countries rapidly expanding their presence in international trade and foreign direct investment. However, the extent to which the deliberate outward orientation of such firms is related to greater domestic economic activity is still a sparse area of research. In particular, whether firms' international activities in the form of exports and outward foreign direct investments (OFDI) affect their technological effort at home remains an important open question.
From a theoretical perspective, recent work in international economics has emphasised that improved access to foreign markets due to trade liberalization encourages firms to undertake complementary investments in technology adoption and innovation. This connection between exporting and technology investments has been modelled and tested empirically in a number of different contexts.
1 For example, Bustos' (2011) provides empirical evidence from Argentina showing that firms in industries facing reductions in Brazil's imports tariffs, as mandated by MERCOSUR, increased their investment in technology faster, and exporters upgraded technology more rapidly than other firms in the same industry. Lileeva and Trefler (2010) show that Canadian plants that were induced to start exporting, or export more, due to the elimination of U.S. tariffs displayed higher rates of technology adoption and innovation. Constantini and Melitz (2008) show how anticipation of trade liberalisation leads firms to innovate in preparation for future participation in export markets, and Atkeson and Burstein (2010) show that a reduction in marginal trade costs induces exporting firms to spend more on process innovation than non-exporting firms, amplifying the superiority of exporting firms over time.
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While the above models have focused on the technological effects of improved access to foreign markets in the context of liberalization of trade regimes, the technological effects resulting from the increased access to foreign markets due to outward FDI liberalization has been absent from existing theoretical work in international economics. This issue is particularly relevant in the context of developing countries where capital controls have been relaxed in recent years, allowing an increasing number of firms to rapidly expand their international operations. However, as yet, little effort has been devoted to investigating the effect of such investments on firms' technological performance at home. The international business literature, on the other hand, has focused primarily on understanding the characteristics and motivations of developing countries multinationals to invest abroad, but little is known about the consequences of such investments for the investing firms in their home countries.
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Understanding the role of outward FDI for technological improvements in the home country is central as there is a considerable concern as to whether the activities of multinational enterprises affect the home economies; an issue that is particularly relevant in the context of developing countries with scarce capital. On one hand, flows of outward foreign direct investment generate fears that such investments come at the cost of reducing economic activity at home. In contrast, an alternative perspective suggests that greater outward foreign direct investment could enrich home activities by improving the competitiveness of the parent investing firms (Desai, et. al., 2005) . countries with the purpose of quickly acquiring new products and foreign knowledge, rather than using their limited resources in costly long-term innovations (Pradhan, 2008) . 6 As such, it is expected that the overseas investments of Indian pharmaceutical firms may substitute domestic investments in technology.
However, on the other hand, it might be the case that a potential foreign market expansion induced by firms' overseas investments would encourage greater technological investments at home, as greater sales create more incentives to invest in costly technology. This potential channel for in-house technological improvements is tested in this paper by looking at the relevance of a firm's multinational (OFDI) status for the technology-exporting link. In line with the insights from recent models of exporting and technology adoption, it is likely that the increase in exports that have accompanied the recent wave of overseas investments by Indian pharmaceutical companies might have provided them with a new impetus to upgrade their technological capabilities at home.
Controlling for unobserved firm heterogeneity and the endogeneity of the choice of foreign market participation, this paper shows that the export-intensity of Indian pharmaceutical multinationals is associated with higher rates of technology adoption. However, there is no evidence that the exports of non-multinational firms stimulate greater technology activity. These results highlight the importance of taking the interaction between exporting and firm's multinational status into account. Another major finding is that OFDI appears to substitute technology investments at home, suggesting that technology-seeking overseas investments tend to divert national resources from home to foreign countries rather than enriching domestic technological activities.
The remainder of the paper is structured as follows. The next section presents the empirical approach. Section 3 describes the dataset. Section 4 reports the main findings from the econometric estimations, and Section 5 concludes.
Empirical approach
This section describes the empirical approach used to identify the individual and combined effects of exporting and OFDI on the rate of technology adoption. The following non-linear panel data model of technology investment describes technology investment in the current period in terms of the previous period's firm characteristics:
where i and t index firms and time periods respectively. The dependent variable is the amount of technology investment (I) normalised by total assets (K) 7 , fi denotes time-invariant firm-specific heterogeneity and is a random error term. In the above model EXP and OFDI capture the export intensity and the amount of OFDI respectively. The export intensity is also interacted with the firm's multinational status (MNE) to allow for the fact that the investment-export nexus is likely to differ for multinational and non-multinational companies.
Firm age captures learning-by-doing effects, whereas firm size reflects the extent to which economies of scale enhance firms' ability to undertake performance-enhancing investment. A firm's internal liquidity is also likely to affect its ability to fund the cost of technological investments.
To allow for this possibility the cashflow ratio is included as a measure of firm's internal liquidity.
Another control variable is firm's productivity, which may impact technology investments in two opposing ways. On one hand, more productive firms may be more likely to afford investing in further productivity improvements (Bustos, 2011) . On the other hand, least productive firms may investment more to catch-up with their competitors, which is consistent with the notion of firm level productivity-convergence (e.g. Bernard and Jones, 1996) .
Finally, Equation 1 is estimated using a full vector of time dummies (Dt ) and a vector of two dummy variables (OWNi), which indicate whether the firm belongs to a business group and whether the firm is owned by the State, respectively.
The treatment of the time-invariant unobserved heterogeneity, fi , and its relationship with the explanatory variables, constitutes an important concern when estimating equation 1. In nonlinear panel data models with small time periods, it is not possible to treat the unobservables as fixed parameters to be estimated by standard maximum likelihood due to the incidental parameter problem. In order to identify the partial effects of the explanatory variables, this paper adopts the Mundlak-Chamberlain approach by modelling the distribution of fi in a parametrical way. A common practice is to assume a linear relationship between fi and either the time means of the explanatory variables or a combinations of their lags and leads. In terms of implementation this approach has the effect of adding firm-specific time averages (or a full set of leads and lags) of the regressors to the set of explanatory variables in Equation 1 (Wooldridge, 2008 (Wooldridge, , 2009 ).
However, a potential problem with this approach is that it relies on the assumption of strict exogeneity of the explanatory variables conditional on the unobserved effects. But arguably, some explanatory variables in Equation 1 (i.e. productivity, size, liquidity, exporting and OFDI ) might be contemporaneously determined with, or even impacted by firms' technology investments. In ; 2) obtaining the reduced residuals from these estimations;
3) including these residuals in the list of covariates in Equation 1; and 4) performing the estimations using a pooled Tobit model with robust standard errors clustering at the firm level. The hypothesis of strict exogeneity is rejected if the coefficients on the residuals are significantly different from zero (Wooldridge, 2008) .
Database description
This paper draws on the Prowess database compiled from audited company balance sheets and income statements by the Centre for Monitoring the Indian Economy. Prowess covers both publicly listed and unlisted firms from a wide cross-section of manufacturing, services, utilities, and financial industries. The companies covered by the database account for more than 70% of industrial output, 75% of corporate taxes and more than 95% of excise taxes collected by the Government of India. Table 1 gives the frequency distribution of the pharmaceutical firms in the sample by year and global status. Firms in Table 1 have been classified in five categories. The first category comprises those Indian firms that only serve the domestic market. The second group includes Indian firms that also export. The third category consists of those indigenous firms that export and invest abroad (Indian MNEs). The fourth group are those Indian MNEs that invest abroad but do not export, and the last category comprises all foreign firms operating in India. The category of foreign firms is dropped from the empirical analysis, since the main interest of this paper is to examine whether exporting and investing abroad has encouraged technology upgrading by indigenous companies in India. It can be observed that the number of Indian pharmaceutical multinationals started to show a marked increase after 2000. This increase is largely due to significant improvements in the regulatory framework governing Indian outward investment. For example, since 2000 Indian companies have been allowed to make overseas investments by market purchases of foreign exchange without the approval of the Reserve Bank of India up to 400% of their net worth, compared to the previous limit of 50%. It is also interesting to note that most Indian MNEs are engaged in exports. During the whole period, only a few pharmaceutical firms set up operations abroad without exporting. Since the sample size is very small for this group of firms for all years, this category of firms is also dropped from the empirical analysis.
[ Table 1 about here]
The variables used in the regression analysis are defined in Table 1A in the appendix and their summary statistics are given in Table 2 . Table 2 shows that about 59 percent of firms undertake technology investments and that, on average, these firms invest 4 percent of their total assets in technology. Table 2 also shows that, on average, more than 60% of pharmaceutical firms export and the fraction of output exported increased from 24% in the first half of the sample (1999) (2000) (2001) (2002) to 28% in the second half. The percentage of firms engaged in overseas investments and the amount of such investments also displayed significant increases between the two periods.
[ Table 2 about here]
Figures 2 depicts the share of firm-year observations and technology investment ordered by exporting and OFDI status. It is striking that although only 9.5% of pharmaceutical firms engaged in both exporting and OFDI, they enjoyed a disproportionately high share of the value technology investment, compare to the significantly larger fraction of firms that only export. This appears to reinforce the idea that export-oriented Indian multinationals appear to be most willing to develop their technological capabilities.
[Figures 2 about here]
In order to isolate the causal effects of exporting and OFDI on the rate of technology adoption as well as to evaluate the interaction between them, it is important to control for a host of observable and unobservable firm characteristics. This is achieved within the non-linear panel data framework described in the previous section. Table 2A in the appendix. The marginal effects are calculated at the sample averages of the control variables and the standard errors are adjusted to allow for clustering at the firm level.
Empirical findings
In order to make this work comparable to previous related research, the first column of Table 3 reports the individual effects of exporting and OFDI on firm's technology investments without accounting for firm heterogeneity. Similar to previous research examining the determinants of R&D in the context of India (Pradhan, 2002 (Pradhan, , 2009 2010) , the results show that firms' export intensity is positively associated with the pace of technology upgrading. However, in this specification the amount of overseas investments does not appear to have significant technological effects.
[ Table 3 about here]
To allow for the fact that the technology-exporting nexus is likely to differ for multinational and non-multinational companies, in column 2 of Table 3 Table 2 . This finding is consistent with the notion of market-seeking exporting Indian MNEs being induced to invest in technology at home in order to become more competitive in international markets. The results in column 2 of Table 3 also uncover evidence of a substantial substitutive effect of firms' overseas investments on their rate of technology investments at home.
The estimates show that all else constant a 1 percentage point increase in outward FDI reduces the amount of firms' technology investments by 0.011 percentage points.
The previous results do not account for potential unobserved firm heterogeneity.
However, it is likely that firms' international activities in the form of exports and overseas investments are correlated with unobserved factors, such as managerial quality or risk behaviour, that also influence their technological decisions. In column 3 of Table 3 firm's heterogeneity is accounted for by including the mean values of the covariates, as described in section 2. The results confirm the previous findings, indicating that the exports of Indian multinational firms are a channel through which firm's multinational expansion enhances technology investments at home and that the higher the level of outward FDI, the lower the rate of domestic technology investments.
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As mentioned in Section 2, the above approach relies on the assumption of strict exogeneity once firm's unobserved heterogeneity is controlled for. However, this assumption might be violated. For example, it might be plausible that a firm's technological effort might affect its export and/or outward FDI strategies. To check whether the previous results are driven by the assumption of strict exogeneity conditional on firm's unobserved effects, column 4 of Table 3 presents the results of using a control function approach, where the residuals from estimating a reduced form of each hypothesised endogenous variable are included in the list of covariates.
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As judged by the significance of the coefficients on the reduced residuals, it appears that firm's size, total factor productivity and outward FDI are likely to be endogenous (see column 4 of Table   2A in the appendix). Interestingly, while the magnitude of the positive technological effects of the exports of Indian MNEs remains almost unchanged, the magnitude of the negative impact of overseas investments on firms' technological efforts increases significantly once firm's heterogeneity and the potential endogeneity of some regressors are accounted for. The estimate results show that a 1 percentage point increase in outward FDI reduces the amount of firms'
technology by approximately 0.04 percentage points. This effect is almost 4 times higher than the effect presented in column 2.
The previous results are obtained using the whole unbalanced panel dataset of Indian pharmaceutical firms. Therefore, there is a potential risk that they might suffer from attrition bias.
In order to check whether the results are robust to this potential problem, column 5 in Table 3 reports the estimation results using only the subset of firms that are observed for all years. These estimates confirm that overseas investments and firms' technology investments at home are substitutive activities, with these negative effects being stronger in the balanced dataset. The results also confirm the positive effects of exporting amongst Indian MNEs.
So far, the combined effects between exporting and firms' multinational status have been accounted for by interacting the export intensity with a dummy variable for Indian MNEs (i.e.
Indian firms with positive overseas investments). This approach treats all Indian MNEs with large
and small overseas investments symmetrically. However, in order to check whether the technology-exporting link of Indian MNEs varies with the amount of OFDI, in column 6 of Table 3 Table 3 .
To check that the results presented in Table 3 are not inconsistent due to the imposed parametric specification of unobserved firm's heterogeneity (i.e. as a linear function of firmspecific time average of the regressors), columns 1 to 4 in Table 4 Table 3 .
In addition, in order to allow firm's heterogeneity to be correlated with the regressors in an unrestrictive way, columns 5 to 8 in Table 4 report the estimated results from a linear fixed effect model. As before, these results show that the exports of Indian multinationals exert a positive effect on the rate of technology investments at home, whereas the amount of overseas investments acts as a substitute for such investments.
[ Table 4 about here] Overall, the previous results highlight the importance of taking the interaction between exporting and multinational status into account and suggest that incurring the fixed cost of investing in technology is only attractive for exporting firms that have become multinationals in recent years, probably due to the larger sales in foreign markets that come with their overseas investments. The lack of evidence of technology enhancing effects from exporting amongst nonmultinational firms suggests that possibly these firms were induced to invest in technology in the past, when they started to export, but now, with less scope to improve foreign market access, they have less incentive to continue to upgrade their technological base. This is an interesting result, as the fundamental complementarity between exporting and investing abroad -in particular, the increase in foreign market access that comes with overseas investments-has been absent from the existing work on trade and technology investments.
Does the industry matter?
So far the analysis has focused on the pharmaceutical industry. As argued in the introduction, there are good reasons for the choice of this industry, in particular its leadership in overseas investments by Indian manufacturing firms; as well as the well-documented behaviour of firms from this industry investing abroad with the purpose of acquiring global technologies to overcome their limited capabilities. Nonetheless, it is interesting to consider another equally important global oriented sector in India. Within the service sector, the Indian software industry is the top industry in terms of Indian outward FDI. This industry offers an intriguing contrast to the pharmaceutical industry, not only for being predominantly service-based, but also because firms in this industry are considered to be technological leaders in a global scale. Therefore, the motivations behind their overseas investments are more for technological diversification rather than for technological acquisition (Pradhan, 2008) . As such, there is not so much scope for further domestic technological improvements in this industry. Estimation results using data from this industry show no effects from exporting and/or outward FDI on firms' domestic technology investments.
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These contrasting results highlight the importance of taking into account the sectoral heterogeneity of exporting and OFDI performance when evaluating the effects of globalization on firms' technological efforts.
Conclusion
Recent work in international economics has shown that improved access to foreign markets due to trade liberalization encourages firms to undertake complementary technology investments.
Using firm-level data from the pharmaceutical industry in India, this paper contributes to this literature by examining whether the increase in foreign market access that comes with overseas investments also encourages indigenous firms to upgrade their technological capabilities at home.
The analysis accounts for unobserved firm heterogeneity and the endogeneity of the choice of foreign market participation, and shows that the decision to invest abroad is crucial in determining the technology-exporting link. While there is evidence of technology-enhancing effects from exporting amongst Indian multinationals, this paper fails to find evidence that exporting nonmultinational firms invest more in technology than non-exporting ones. This finding is consistent with the notion of market-seeking exporting Indian multinationals being encouraged to invest in technology at home in order to take advantage of improved foreign market access and become more competitive abroad. Another striking result from this paper is the negative relationship between the level of overseas investment (OFDI) and firms' domestic technology investments, a result that is consistent with the notion of technology-seeking Indian multinational firms devoting their scarce resources to accessing existing technology abroad.
Overall, this study contributes to academic efforts that seek to pin down the channels through which the choice of foreign market participation shapes firms' competitive advantages. In particular, this paper informs existing economic theory by cautioning for the need to consider the heterogeneous nature of the exporting-technology investment link and take explicit account of the OFDI decision when examining this link.
From a policy perspective, this paper shows that although outward FDI has a negative effect on firms' domestic technological efforts (a concern that has been raised amongst some academics and policy makers), the potential increase in exports induced by overseas investments creates an alternative opportunity for technological improvements at home. Policies aimed at promoting export-oriented OFDI can therefore be conducive for technological upgrading in the home economies. However, OFDI with the singular purpose of acquiring foreign technology might help the investing firms to overcome their lack of state-of-the art technology, but that would come at the cost of discouraging technology change in their home countries.
Overall, conclusions regarding the role of outward FDI for technology enhancing investments should take into account the motivations behind such overseas investments. In the case of Indian pharmaceutical firms it has been documented that outward FDI are mainly motivated by the desire to improve foreign market access (market-seeking motivation) and acquire foreign technology (technology-seeking motivation). As such, these effects are likely to operate in opposite directions. Source: Author's analysis based on the Prowess dataset. Marginal effects on the expected amount of technology investments are calculated at the sample means of the regressors. c. Standard errors (clustered at firm level) in parentheses d. *significant at 10%; ** significant at 5%; *** significant at 1% All specifications include the full set of time dummies. All results based on a pooled Tobit model b. Standard errors (clustered at firm level) in parentheses c. *significant at 10%; ** significant at 5%; *** significant at 1% All specifications include the full set of time dummies
